TD Asset Management’s AnaptysBio ANAB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-14,000
| Closed | -$260K | – | 1197 |
|
2025
Q1 | $260K | Hold |
14,000
| – | – | ﹤0.01% | 1183 |
|
2024
Q4 | $185K | Sell |
14,000
-48,000
| -77% | -$636K | ﹤0.01% | 1231 |
|
2024
Q3 | $1.98M | Buy |
62,000
+24,200
| +64% | +$771K | ﹤0.01% | 1049 |
|
2024
Q2 | $947K | Buy |
37,800
+15,200
| +67% | +$381K | ﹤0.01% | 1172 |
|
2024
Q1 | $509K | Sell |
22,600
-8,800
| -28% | -$198K | ﹤0.01% | 1293 |
|
2023
Q4 | $673K | Hold |
31,400
| – | – | ﹤0.01% | 1259 |
|
2023
Q3 | $564K | Buy |
+31,400
| New | +$564K | ﹤0.01% | 1252 |
|
2019
Q4 | – | Sell |
-19,122
| Closed | -$669K | – | 1396 |
|
2019
Q3 | $669K | Sell |
19,122
-3,022
| -14% | -$106K | ﹤0.01% | 1132 |
|
2019
Q2 | $1.25M | Buy |
22,144
+1,635
| +8% | +$92.2K | ﹤0.01% | 1006 |
|
2019
Q1 | $1.5M | Buy |
20,509
+6,400
| +45% | +$467K | ﹤0.01% | 967 |
|
2018
Q4 | $900K | Buy |
14,109
+1,300
| +10% | +$82.9K | ﹤0.01% | 1082 |
|
2018
Q3 | $1.28M | Buy |
12,809
+4,609
| +56% | +$460K | ﹤0.01% | 1101 |
|
2018
Q2 | $583K | Sell |
8,200
-1,000
| -11% | -$71.1K | ﹤0.01% | 1237 |
|
2018
Q1 | $958K | Buy |
9,200
+4,800
| +109% | +$500K | ﹤0.01% | 1073 |
|
2017
Q4 | $443K | Buy |
+4,400
| New | +$443K | ﹤0.01% | 1208 |
|